MR Vaccine Administration Guidelines

Introduction to Vaccination Guidelines

The Advisory Committee on Immunization Practices (ACIP) guidelines state that minor illnesses are not contraindications for vaccination and vaccination should not be postponed because of them, according to the Centers for Disease Control and Prevention (CDC) 1, 2

Vaccination should only be deferred for moderate or severe febrile illness, severe immunosuppression, recent administration of immune globulin products, or pregnancy, as recommended by the ACIP 1, 2, 3, 4

The ACIP guidelines explicitly list conditions that are NOT contraindications, including diarrhea, upper respiratory infections, otitis media, and minor illnesses with or without fever, as stated by the CDC 1
Deworming treatment is not a contraindication for vaccination, as it does not suppress immune function or interfere with vaccine response, according to the ACIP 1

The ACIP recommends assessing the child's current clinical status, including whether the child is well-appearing and has any moderate or severe febrile illness, before deciding to vaccinate, as outlined by the CDC 1
If the child appears healthy or has only minor symptoms, vaccination should be administered today, as recommended by the ACIP 1, 2

The ACIP advises against postponing vaccination for routine medical interventions like deworming, as this creates unnecessary delays in protection and missed opportunities, according to the CDC 1
Routine physical examinations or temperature measurements should not be required before vaccinating children who appear to be in good health, as stated by the ACIP 1, 2
Medical personnel should use every opportunity to vaccinate susceptible persons, because of the importance of protecting children against measles and rubella, as recommended by the CDC 1, 2

Dermatologic conditions such as atopic dermatitis, urticaria, angioedema, and contact dermatitis are not listed as contraindications for the measles‑mumps‑rubella (MMR) vaccine by the Advisory Committee on Immunization Practices (ACIP) — children with these stable skin disorders may follow the routine immunization schedule. 5, 6
The only true contraindications to MMR vaccination are a severe allergic reaction (anaphylaxis) to a prior dose or vaccine component, severe immunosuppression, pregnancy, and recent administration of immune globulin. These apply regardless of dermatologic history. 5, 7

For children with stable atopic dermatitis, contact dermatitis, chronic urticaria, or angioedema, administer MMR on the standard timetable: first dose at 12–15 months of age and second dose at 4–6 years of age. No special precautions, pre‑medication, or allergy testing are required. 5, 6

The ACIP advises that vaccination should not be withheld due to parental worries about potential worsening of atopic dermatitis; the protective benefits of MMR far outweigh any theoretical risk of disease flare. 8